Some studies show a decrease in thyroid volume, by up to 25%, after normalization of IGF-1, achieved through successful surgical removal of somatotropinoma, or by medical treatment with somatostatin analogs ( 6 , 15 , 16 ). The gene discussed is IGF1; the disease is growth hormone-producing pituitary gland neoplasm.